Synopsis:
HEG shares are in focus after a 356% revenue leap and a Rs. 650 crore enlargement plan to spice up graphite electrode capability by 15,000 TPA.
A number one producer identified for its industrial merchandise has reported explosive monetary progress alongside main enlargement plans. This text particulars the staggering 356% year-on-year revenue leap and the announcement of a big Rs. 650 crore funding aimed toward boosting manufacturing capability to fulfill rising demand.
HEG Restricted’s inventory, with a market capitalisation of Rs. 11,404 crores, rose to Rs. 594, hitting a excessive of as much as 11.2 p.c from its earlier closing worth of Rs. 534.25. Moreover, the inventory over the previous yr has given a return of 32.4 p.c.
Steerage
The Board has permitted a capability enlargement plan for graphite electrodes and associated merchandise, aiming so as to add 15,000 TPA to the present 1,00,000 TPA capability, which is at present utilised at 85% to 90%. The enlargement is predicted to be accomplished over 30 months, with an estimated funding of Rs. 650 crore, to be financed by inner accruals and debt if vital.
Additionally learn: Inventory Cut up: Tata Group inventory jumps after firm’s board set to think about share break up
Q1 Monetary Replace
The corporate reported a income of Rs. 617 crore in Q1FY26, reflecting an 8 p.c YoY progress from Rs. 571 crore in Q1FY25 and a 13.9 p.c QoQ enhance from Rs. 542 crore in Q4FY25. Revenue after tax stood at Rs. 105 crore, a powerful restoration from a lack of Rs. 74 crore in Q1FY25 and a 356 p.c leap from Rs. 23 crore in Q4FY25.
Regardless of the latest enchancment, the corporate’s 3-year monetary efficiency stays weak, with a detrimental revenue CAGR of -36 p.c and a flat gross sales CAGR of -1 p.c. Nonetheless, return on fairness has grown at a 3-year CAGR of seven p.c, indicating some enchancment in capital effectivity.
Written By Fazal Ul Vahab C H
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Personal Restricted or the writer will not be chargeable for any losses precipitated on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
